BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 23948971)

  • 1. CD62L as a therapeutic target in chronic lymphocytic leukemia.
    Burgess M; Gill D; Singhania R; Cheung C; Chambers L; Renyolds BA; Smith L; Mollee P; Saunders N; McMillan NA
    Clin Cancer Res; 2013 Oct; 19(20):5675-85. PubMed ID: 23948971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thioredoxin, produced by stromal cells retrieved from the lymph node microenvironment, rescues chronic lymphocytic leukemia cells from apoptosis in vitro.
    Bäckman E; Bergh AC; Lagerdahl I; Rydberg B; Sundström C; Tobin G; Rosenquist R; Linderholm M; Rosén A
    Haematologica; 2007 Nov; 92(11):1495-504. PubMed ID: 18024398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Down-regulation of CXCR4 and CD62L in chronic lymphocytic leukemia cells is triggered by B-cell receptor ligation and associated with progressive disease.
    Vlad A; Deglesne PA; Letestu R; Saint-Georges S; Chevallier N; Baran-Marszak F; Varin-Blank N; Ajchenbaum-Cymbalista F; Ledoux D
    Cancer Res; 2009 Aug; 69(16):6387-95. PubMed ID: 19654311
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of trisomy 12 by fluorescence in situ hybridization in peripheral blood, bone marrow and lymph nodes of patients with B-cell chronic lymphocytic leukemia.
    Liso V; Capalbo S; Lapietra A; Pavone V; Guarini A; Specchia G
    Haematologica; 1999 Mar; 84(3):212-7. PubMed ID: 10189384
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of CD10 by B-chronic lymphocytic leukemia cells undergoing apoptosis in vivo and in vitro.
    Morabito F; Mangiola M; Rapezzi D; Zupo S; Oliva BM; Ferraris AM; Spriano M; Rossi E; Stelitano C; Callea V; Cutrona G; Ferrarini M
    Haematologica; 2003 Aug; 88(8):864-73. PubMed ID: 12935974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of the chemokine receptors CXCR4 and CCR7 and disease progression in B-cell chronic lymphocytic leukemia/ small lymphocytic lymphoma.
    Ghobrial IM; Bone ND; Stenson MJ; Novak A; Hedin KE; Kay NE; Ansell SM
    Mayo Clin Proc; 2004 Mar; 79(3):318-25. PubMed ID: 15008605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic lymphocytic leukemia cells induce anti-apoptotic effects of bone marrow stroma.
    Plander M; Ugocsai P; Seegers S; Orsó E; Reichle A; Schmitz G; Hofstädter F; Brockhoff G
    Ann Hematol; 2011 Dec; 90(12):1381-90. PubMed ID: 21465189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone marrow stromal mesenchymal cells induce down regulation of CD20 expression on B-CLL: implications for rituximab resistance in CLL.
    Marquez ME; Hernández-Uzcátegui O; Cornejo A; Vargas P; Da Costa O
    Br J Haematol; 2015 Apr; 169(2):211-8. PubMed ID: 25612644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sorafenib induces cell death in chronic lymphocytic leukemia by translational downregulation of Mcl-1.
    Huber S; Oelsner M; Decker T; zum Büschenfelde CM; Wagner M; Lutzny G; Kuhnt T; Schmidt B; Oostendorp RA; Peschel C; Ringshausen I
    Leukemia; 2011 May; 25(5):838-47. PubMed ID: 21293487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hedgehog-induced survival of B-cell chronic lymphocytic leukemia cells in a stromal cell microenvironment: a potential new therapeutic target.
    Hegde GV; Peterson KJ; Emanuel K; Mittal AK; Joshi AD; Dickinson JD; Kollessery GJ; Bociek RG; Bierman P; Vose JM; Weisenburger DD; Joshi SS
    Mol Cancer Res; 2008 Dec; 6(12):1928-36. PubMed ID: 19074837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aberrant expression of TRAIL in B chronic lymphocytic leukemia (B-CLL) cells.
    Secchiero P; Tiribelli M; Barbarotto E; Celeghini C; Michelutti A; Masolini P; Fanin R; Zauli G
    J Cell Physiol; 2005 Nov; 205(2):246-52. PubMed ID: 15887227
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stimulation of B-chronic lymphocytic leukemia cells by murine fibroblasts, IL-4, anti-CD40 antibodies, and the soluble CD40 ligand.
    Buske C; Gogowski G; Schreiber K; Rave-Fränk M; Hiddemann W; Wörmann B
    Exp Hematol; 1997 Apr; 25(4):329-37. PubMed ID: 9131008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tris (dibenzylideneacetone) dipalladium: a small-molecule palladium complex is effective in inducing apoptosis in chronic lymphocytic leukemia B-cells.
    Kay NE; Sassoon T; Secreto C; Sinha S; Shanafelt TD; Ghosh AK; Arbiser JL
    Leuk Lymphoma; 2016 Oct; 57(10):2409-16. PubMed ID: 27189785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Divergence in CD19-mediated signaling unfolds intraclonal diversity in chronic lymphocytic leukemia, which correlates with disease progression.
    Herishanu Y; Kay S; Dezorella N; Baron S; Hazan-Halevy I; Porat Z; Trestman S; Perry C; Braunstein R; Deutsch V; Polliack A; Naparstek E; Katz BZ
    J Immunol; 2013 Jan; 190(2):784-93. PubMed ID: 23241880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of the RANKL/RANK system in the induction of interleukin-8 (IL-8) in B chronic lymphocytic leukemia (B-CLL) cells.
    Secchiero P; Corallini F; Barbarotto E; Melloni E; di Iasio MG; Tiribelli M; Zauli G
    J Cell Physiol; 2006 Apr; 207(1):158-64. PubMed ID: 16270354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms of apoptosis-induction by rottlerin: therapeutic implications for B-CLL.
    Ringshausen I; Oelsner M; Weick K; Bogner C; Peschel C; Decker T
    Leukemia; 2006 Mar; 20(3):514-20. PubMed ID: 16437144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the in vitro effects of the anti-CD20 antibodies rituximab and GA101 on chronic lymphocytic leukaemia cells.
    Patz M; Isaeva P; Forcob N; Müller B; Frenzel LP; Wendtner CM; Klein C; Umana P; Hallek M; Krause G
    Br J Haematol; 2011 Feb; 152(3):295-306. PubMed ID: 21155758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extracellular vesicles of bone marrow stromal cells rescue chronic lymphocytic leukemia B cells from apoptosis, enhance their migration and induce gene expression modifications.
    Crompot E; Van Damme M; Pieters K; Vermeersch M; Perez-Morga D; Mineur P; Maerevoet M; Meuleman N; Bron D; Lagneaux L; Stamatopoulos B
    Haematologica; 2017 Sep; 102(9):1594-1604. PubMed ID: 28596280
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antileukemic activity of valproic acid in chronic lymphocytic leukemia B cells defined by microarray analysis.
    Stamatopoulos B; Meuleman N; De Bruyn C; Mineur P; Martiat P; Bron D; Lagneaux L
    Leukemia; 2009 Dec; 23(12):2281-9. PubMed ID: 19710697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating B-cell chronic lymphocytic leukemia cells display impaired migration to lymph nodes and bone marrow.
    Hartmann TN; Grabovsky V; Wang W; Desch P; Rubenzer G; Wollner S; Binsky I; Vallon-Eberhard A; Sapoznikov A; Burger M; Shachar I; Haran M; Honczarenko M; Greil R; Alon R
    Cancer Res; 2009 Apr; 69(7):3121-30. PubMed ID: 19293181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.